Diphenylhydantoin.
D000342:Affective Symptoms / Q000188:drug therapy*; D001145:Arrhythmias, Cardiac / Q000188:drug therapy*; D001259:Ataxia / Q000139:chemically induced; D002220:Carbamazepine / Q000627:therapeutic use; D002493:Central Nervous System Diseases; D056486:Chemical and Drug Induced Liver Injury / Q000209:etiology; D004827:Epilepsy / Q000188:drug therapy*; D005885:Gingival Hyperplasia / Q000139:chemically induced; D006323:Heart Arrest / Q000139:chemically induced; D006801:Humans; D008881:Migraine Disorders / Q000188:drug therapy*; D009497:Neurotic Disorders / Q000188:drug therapy; D009759:Nystagmus, Pathologic / Q000139:chemically induced; D010672:Phenytoin / Q000009:adverse effects / Q000627:therapeutic use*; D010488:Polyarteritis Nodosa / Q000139:chemically induced; D012131:Respiratory Insufficiency / Q000139:chemically induced; D012871:Skin Diseases / Q000139:chemically induced; D013064:Speech Disorders / Q000139:chemically induced; D013262:Stevens-Johnson Syndrome / Q000139:chemically induced; D014277:Trigeminal Neuralgia / Q000188:drug therapy*; D014693:Ventricular Fibrillation / Q000139:chemically induced
D002220:Carbamazepine; D010672:Phenytoin